4.5 Article

Impact of thyroid disorders on the incidence of non-alcoholic fatty liver disease in Germany

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Gastroenterology & Hepatology

Administrative Coding in Electronic Health Care Record-Based Research of NAFLD: An Expert Panel Consensus Statement

Hannes Hagstrom et al.

Summary: By reaching consensus on ICD codes for EHR-based research, the generalizability and comparability of research results can be improved. The expert panel achieved high agreement and provided a detailed list of ICD codes for exposures and outcomes, along with suggestions for addressing common methodological issues.

HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis in five European countries in 2018: A cost-of-illness analysis

Jorn M. Schattenberg et al.

Summary: This study estimated the disease burden and economic impact of diagnosed NASH in the adult population of France, Germany, Italy, Spain, and the United Kingdom in 2018. The majority of undiagnosed NASH patients were found to have early-stage disease, which may progress to more resource-consuming late-stage liver disease in the future. The results suggest that the majority of economic and wellbeing costs of NASH are experienced in late disease stages, highlighting the importance of earlier diagnosis and care to reduce future healthcare costs.

LIVER INTERNATIONAL (2021)

Article Medicine, General & Internal

Relationship between hypothyroidism and non-alcoholic fatty liver disease in the Spanish population

Alba Martinez Escude et al.

MEDICINA CLINICA (2020)

Review Endocrinology & Metabolism

Nonalcoholic Fatty Liver Disease in Adults: Current Concepts in Etiology, Outcomes, and Management

Thomas Marjot et al.

ENDOCRINE REVIEWS (2020)

Article Gastroenterology & Hepatology

Non-alcoholic fatty liver disease increases the risk of incident chronic kidney disease

Leonard Kaps et al.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2020)

Article Medicine, General & Internal

Tumor Incidence in Patients with Non-Alcoholic Fatty Liver Disease

Yvonne Huber et al.

DEUTSCHES ARZTEBLATT INTERNATIONAL (2020)

Article Gastroenterology & Hepatology

Nonalcoholic Fatty Liver Disease Increases the Risk of Anxiety and Depression

Christian Labenz et al.

HEPATOLOGY COMMUNICATIONS (2020)

Review Gastroenterology & Hepatology

Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

Zobair Younossi et al.

HEPATOLOGY (2019)

Article Gastroenterology & Hepatology

Multicenter Validation Study of a Diagnostic Algorithm to Detect NASH and Fibrosis in NAFLD Patients With Low NAFLD Fibrosis Score or Liver Stiffness

Stephanie Liebig et al.

CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2019)

Editorial Material Gastroenterology & Hepatology

Refining Noninvasive Diagnostics In Nonalcoholic Fatty Liver Disease: Closing the Gap to Detect Advanced Fibrosis

Joern M. Schattenberg et al.

HEPATOLOGY (2019)

Article Pharmacology & Pharmacy

Basic characteristics and representativeness of the German Disease Analyzer database

Wolfgang Rathmann et al.

INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2018)

Article Gastroenterology & Hepatology

Predictors of advanced fibrosis in non-cirrhotic non-alcoholic fatty liver disease in Germany

Christian Labenz et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)

Article Endocrinology & Metabolism

Histopathologic Evaluation of Nonalcoholic Fatty Liver Disease in Hypothyroidism-Induced Rats

Sule Demir et al.

INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2016)

Article Gastroenterology & Hepatology

Non-alcoholic steatohepatitis: Pathogenesis and novel therapeutic approaches

Detlef Schuppan et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)

Review Biochemistry & Molecular Biology

Nonalcoholic steatohepatitis: the therapeutic challenge of a global epidemic

Joern M. Schattenberg et al.

CURRENT OPINION IN LIPIDOLOGY (2011)

Article Multidisciplinary Sciences

Selective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice

L Johansson et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)